Seagen investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of seagen inc. - sgen

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of seagen inc. (nasdaqgs: sgen) to pfizer inc. (nyse: pfe). under the terms of the proposed transaction, shareholders of seagen will receive $229 in cash for each share of seagen that they own.
SGEN Ratings Summary
SGEN Quant Ranking